Skip to content
healthcare.dev
Get a free key

MUCUS RELIEF GUAIFENESIN EXTENDED-RELEASE 1200 mg

NDC 73581-402, GUAIFENESIN, tablet, from YYBA CORP.

Product NDC
73581-402
Status
Listed
Labeler
YYBA CORP
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA213420
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73581-402 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN1200 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
73581-402-0173581040201100 TABLET in 1 BOTTLE (73581-402-01)
73581-402-107358104021010 TABLET in 1 BOTTLE (73581-402-10)
73581-402-357358104023535 TABLET in 1 BOTTLE (73581-402-35)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 73581-402 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73581-402 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73581-402. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.